3D model is for representation purpose only.
.
.
GFLGTKPKG | glycolic acid | N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide |
Identification | |
---|---|
ConjuPepDB ID | cpd00117 |
Smiles | |
Inchi Key | InChIKey=IVOBBDGNRILTJP-POYMZKDISA-N |
Molecular weight | 1290.54 |
Molecular formula | C59H83BrN14O14 |
Chemical name | Peptide information |
Sequence (one letter) | GFLGTKPKG |
Length | 9 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 2100270-42-4 |
Other information | |
---|---|
Application | Antimicrobial therapy, anti-tuberculosis |
Additional function | Target cell-directed delivery and fluorescent labeling |
Pharmacological class | antimicrobial, antibacterial |
Conjugate type | amide |
Linker | N/A |
Linker Type | glycolic acid |
Small molecule | N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide |
Small molecule CAS | 1007653-77-1 |
Small molecule structure | |
Structure method | 1H- and 13C-NMR |
Calculated properties | |
---|---|
LogP | -3.27567 |
Rotatable bonds | 36 |
H bond donor | 14 |
H bond acceptor | 17 |
Polar surface area (PSA) | 439.39000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates | 2017 | European Journal of Medicinal Chemistry | European Journal of Medicinal Chemistry |